Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups
Kołecki, P.; Radwańska, U.
Pediatria Polska 63(11): 698-702
1988
ISSN/ISBN: 0031-3939
PMID: 3253656
Accession: 041920936
PDF emailed within 1 workday: $29.90
Related References
Kołecki, P.; Radwańska, U. 1988: Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia Pediatria Polska 63(11): 693-697Kolecki, P. 1986: Immunological subclassification of acute lymphoblastic leukemia in children ii. immunological phenotype and clinical manifestations and prognosis Acta Haematologica Polonica 17(3-4): 103-109
Zhang S.; Ge Y. 1990: Immunological typing of acute lymphoblastic leukemia with monoclonal antibodies Xi'an Yike Daxue Xuebao 11(1): 56-58
Haruta, Y. 1984: Monoclonal antibodies against human null acute lymphoblastic leukemia cell line nall 1 2. 2 unique antibodies specific for leukemia associated antigens Okayama Igakkai Zasshi 96(5-6): 489-502
Chen, G.B.; Tang, M.H.; Yang, T.Y. 1993: The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia Zhonghua Nei Ke Za Zhi 32(6): 405-408
Novikova, M.S.; Miterev, G.I.; Morozova, N.G.; Shakhbazian, G.P.; Bulycheva, T.I. 1990: The use of a panel of monoclonal antibodies for immunologic prognosis of recurrence of acute lymphoblastic leukemia Gematologiia i Transfuziologiia 35(4): 23-26
Zipf, T.F.; Fox, R.I.; Dilley, J.; Levy, R. 1981: Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies Cancer Research 41(11 Part 2): 4786-4789
Riehm, H. 1986: Age predilection of distinct phenotypically defined subgroups of non t cell acute lymphoblastic leukemia studies using b cell restricted or associated monoclonal antibodies in 359 patients Reinherz, E Al. (ed.). Leukocyte Typing Ii, Vol. 2. Human B Lymphocytes; 2nd International Workshop On Human Leukocyte Differentiation Antigens, Boston, Mass., Usa, Sept. 17-20, . Xx 560p. Springer-Verlag: New York, N.y., Usa; Berlin, West Germany. Illus. 377-384
Homans, A.C.; Forman, E.N.; Barker, B.E. 1985: Use of monoclonal antibodies to identify cerebrospinal fluid lymphoblasts in children with acute lymphoblastic leukemia Blood 66(6): 1321-1325
Sang, B.C.; Shi, L.; Dias, P.; Liu, L.; Wei, J.; Wang, Z.X.; Monell, C.R.; Behm, F.; Gruenwald, S. 1997: Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility Blood 89(8): 2909-2914
Makhonova, L.A.; Maiakova, S.A.; Gordina, G.A.; Tupitsyn, N.N.; Kiselev, A.V.; Peterson, I.S.; Gavrilova, I.E.; Moiseenko, E.I.; Baryshnikov, A.I. 1990: Clinical course and prognosis in T-cell lymphoblastic tumors in children typed with Soviet-produced monoclonal antibodies Gematologiia i Transfuziologiia 35(1): 10-14
Stumpel, D.J.P.M.; Schneider, P.; van Roon, E.H.J.; Boer, J.M.; de Lorenzo, P.; Valsecchi, M.G.; de Menezes, R.X.; Pieters, R.; Stam, R.W. 2009: Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options Blood 114(27): 5490-5498
Hixon, J.A.; Andrews, C.; Kashi, L.; Kohnhorst, C.L.; Senkevitch, E.; Czarra, K.; Barata, J.T.; Li, W.; Schneider, J.P.; Walsh, S.T.R.; Durum, S.K. 2020: New anti-IL-7Rα monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models Leukemia 34(1): 35-49
Seon, B.K.; Matsuzaki, H.; Fukukawa, T.; Barcos, M.P.; Minowada, J.; Jackson, A.N.; Shimoyama, M.; Minato, K.; H.K. 1986: Human t cell acute lymphoblastic leukemia specific monoclonal antibodies sn 1 and sn 1a determination of the specificity by means of multiple assay procedures Proceedings of the American Association for Cancer Research Annual Meeting 27: 331
Kubíková, A.; Habancová, M.; Valnícek, S. 1984: Relation between immunological and morphological characteristics and the clinical course in children with acute lymphoblastic leukemia Casopis Lekaru Ceskych 123(19): 578-582
Thiel, E.; Hoelzer, D.; Dörken, B.; Löffler, H.; Messerer, C.; Huhn, D. 1987: Clinical relevance of blast cell phenotype as determined with monoclonal antibodies in acute lymphoblastic leukemia of adults Haematology and Blood Transfusion 30: 95-103
Liu, J.; Lu, A.D.; Zuo, Y.X.; Wu, J.; Huang, Z.Z.; Jia, Y.P.; Ding, M.M.; Zhang, L.P.; Qin, J. 2022: Clinical characteristics and prognosis of seizures in 75 children with acute lymphoblastic leukemia Beijing da Xue Xue Bao. Yi Xue Ban 54(5): 948-953
Kerr, M.W.A.; Magalhães-Gama, F.áb.; Ibiapina, H.N.S.; Hanna, F.ío.S.A.; Xabregas, L.A.; Alves, E.B.; Pimentel, J.ão.P.D.; Carvalho, M.P.ét.S.S.; Tarragô, A.éa.M.; Teixeira-Carvalho, A.éa.; Martins-Filho, O.A.; da Costa, A.G.ãe.; Malheiro, A. 2021: Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy Frontiers in Oncology 11: 696032
Giordano, P.; Del Vecchio, G.C.; Santoro, N.; Arcamone, G.; Coppola, B.; Altomare, M.; Schettini, F.; Iolascon, A.; De Mattia, D. 2000: Thrombin generation in children with acute lymphoblastic leukemia: Effect of leukemia immunophenotypic subgroups Pediatric Hematology and Oncology 17(8): 667-672
Klubovskaya, N.I.; Tsveibakh, A.S.; Petrova, E.M.; Pustovalova, A.G.; Bessonova, A.G.; Tiranova, S.A.; Alekseev, N.A. 1989: The clinical features and prognosis of different immunocytological forms of acute lymphoblastic leukemia in children Pediatriya (Moscow) (2): 30-34